Has Vladimir Fiks, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,094 in general payments to Vladimir Fiks, MD across 153 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vladimir Fiks, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vladimir Fiks, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vladimir Fiks, MD

Interventional Pain Medicine · Portland, ORNPI 1063418333

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,302 of the $8,094 with a category attached, or 65.5%. It is spread thinly across 25 manufacturers, the largest accounting for just 23.1%. That places this record below the midpoint for interventional pain medicine clinicians in OR, where the typical reported total is $8,094.

$8,094in general payments, 2019–2025

Across 153 payments — averaging $52.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vertiflex, Inc.$2K
Boston Scientific$1K
Spinefrontier, Inc.$1K
AbbVie$691
Si-bone, Inc.$577
MML US, Inc.$514
plus $2K from 19 others

What the payments were for

Travel & lodging$2,79234%
Food & beverage$5,30266%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vertiflex, Inc.	8	$1,868
Boston Scientific	27	$1,233
Spinefrontier, Inc.	5	$1,075
AbbVie(2 entities)	26	$691
Si-bone, Inc.	4	$577
MML US, Inc.	17	$514
SPR Therapeutics, Inc	3	$334
Curonix LLC	9	$328
Abbott	16	$267
Biotronik NRO, Inc.	14	$265
Vertos Medical, Inc.	3	$190
Relievant Medsystems, Inc.	2	$176
Globus Medical	2	$136
Medtronic	1	$120
Stimwave Technologies Incorporated	1	$69
Pfizer	3	$44
Merz Pharmaceuticals, LLC	1	$35
Nalu Medical, Inc.	2	$32
Daiichi Sankyo Inc.	2	$30
MDD US Operations, LLC	2	$25
Lilly USA, LLC	1	$20
Collegium Pharmaceutical, Inc.	1	$18
Teva Pharmaceuticals USA, Inc.	1	$17
Novartis	1	$15
Amgen	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Superion ISS$1,772
InSpan$990
SIJFuse$990
FacetFuse$990
NanoFuse$990
IFUSE IMPLANT SYSTEM$514
SPRINT PNS System$305
Intracept$261
GENERAL PAIN MANAGEMENT$256
WaveWriter Alpha Prime 16$150
ReActiv8$128
BOTOX$125
GENERAL - THERAPIES$122
INTELLIS$120
Senza$118
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$101

How this compares

$8,094 in reported general payments places this provider in the 50th percentile of 22 interventional pain medicine providers in Oregon.

See all interventional pain medicine providers in Oregon →

Medicare billing

Part B allowed, 2024

$223,299

Medicare patients

241

Services billed

3,595

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	125	$2,857
Fentanyl	11	$1,900
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	80	$1,584
Morphine Sulfate ErMorphine Sulfate	30	$773
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	38	$727
Gabapentin	35	$399
Tizanidine Hcl	14	$282
Hydromorphone Hcl	21	$178
Celecoxib	20	$162
Cyclobenzaprine Hcl	16	$132
Methadone Hcl	14	$124
Pregabalin	14	$84
Tramadol Hcl	16	$66

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Portland

Carl BalogPortland$12K
Navnit Kaur-JayaramPortland$654
Gregory MooreEugene$377K
Gregory PhillipsEugene$50K
Stephen PeirceEugene$28K
Rishi VoraEugene$16K
George JohnstonMedford$14K
Poly ChenSalem$14K
Kwo Wei HoTigard$13K
Joseph DunnEugene$10K

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →